TFC News
2025-2026 Board of Directors
The Thyroid Foundation of Canada is pleased to announce the 2025-2026 Board of Directors. The nominees were elected at the Annual General Meeting.
CDA Recommends Not to Reimburse Tepezza Drug
Canada’s Drug Agency (CDA) has issued its Draft Reimbursement Recommendation for Tepezza for Thyroid Eye Disease (TED)
June is Thyroid Awareness Month
June is Thyroid Awareness Month in Canada and the Thyroid Foundation of Canada is celebrating its 45th Anniversary! To celebrate our anniversary, we
Health Canada Approves Tepezza
Health Canada approved the tepro-tumumab (Tepezza) drug for thyroid eye disease on April 17, 2025. Tepezza “reduces eye bulging and double vision…”
New Video on Hypothyroidism
The Thyroid Foundation of Canada and BGP Pharma ULC o/a Viatris Canada, have co-sponsored a new video on hypothyroidism with Dr. Sue D. Pedersen to promote public awareness.
RFA Facilities in Canada
The Thyroid Foundation of Canada is providing a list of Radio Frequency Ablation Facilities currently available in Canada for the treatment of thyroid nodules.
